World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 30 January 2023
Main ID:  ISRCTN54878784
Date of registration: 11/06/2013
Prospective Registration: Yes
Primary sponsor: The Autonomous University of Guerrero (Universidad Autónoma de Guerrero) (Mexico)
Public title: A scaled up structural intervention program versus current national HIV prevention program
Scientific title: Inter-ministerial National Structural Intervention Trial: a stepped wedge trial of HIV prevention in Botswana
Date of first enrolment: 01/08/2013
Target sample size: 300000
Recruitment status: Completed
URL:  https://www.isrctn.com/ISRCTN54878784
Study type:  Interventional
Study design:  Stepped-wedge cluster randomised controlled trial, district as unit of allocation, intervention and analysis (Prevention)  
Phase:  Not Applicable
Countries of recruitment
Botswana Mexico
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Neil    Andersson
Address:  CIET, Universidad Autónoma de Guerrero CP39640 Acapulco Mexico
Telephone:
Email:
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria:
For intervention:
All districts will be eligible for randomization to receive the intervention. In each intervention district, all residents aged 15 and above will be eligible. Different intervention activities will address different groups of the population, who will be free to decide whether to take up the offer:
1. Economic empowerment including skills workshop and government structural support offered to women aged 18-24, especially those not in school or employment.
2. Audio-drama discussion groups will be offered to all ages and both sexes
3. Concerting of service provision will include discussions with all local service-providers (all eligible)

For impact surveys: Young women and young men aged 15-29 years in 10 clusters (random selection of enumeration areas from the recent census) in each of five intervention and five non-intervention districts.

Exclusion criteria:
For intervention: No district will be excluded. Within each intervention district, people not resident in the district will be excluded to minimize contamination (by people in other districts hearing of the interventions and wishing to take advantage of them, thus diluting the measured impact).

For impact surveys: Field workers will not interview or take blood samples from anyone they judge to be unable to give informed consent or to understand the survey questions.


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
HIV prevention
Infections and Infestations
Unspecified human immunodeficiency virus [HIV] disease
Intervention(s)

30 districts randomly assigned to intervention groups, stratified by development status and HIV prevalence.

The structural intervention: Activities focus on empowerment of women aged 15-29 years, concerting existing local health, social and other services in favor of the most vulnerable, especially young women, and developing an enabling environment using an audio-drama to stimulate community-wide discussion about gender violence and HIV risk.
Primary Outcome(s)
HIV sero-prevalence among women aged 15-29 years. Outcome measured on completion of the intervention in year 4 and compared with the baseline of the second group of communities
Secondary Outcome(s)
Protective knowledge, attitudes, subjective norms, intention to change, agency, discussion of prevention, behaviours related to gender violence and HIV risk and prevention
Secondary ID(s)
CIET CD2-INSTRUCT
Source(s) of Monetary Support
Government of Botswana (Botswana)
Secondary Sponsor(s)
Ethics review
Status:
Approval date:
Contact:
Not provided at the time of registration
Results
Results available: Yes
Date Posted:
Date Completed: 31/07/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history